Short Interest in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Declines By 29.2%

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHGet Rating) was the target of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 1,670,000 shares, a decline of 29.2% from the March 15th total of 2,360,000 shares. Approximately 3.5% of the company’s shares are sold short. Based on an average daily volume of 535,000 shares, the short-interest ratio is presently 3.1 days.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Voya Investment Management LLC raised its holdings in Aveanna Healthcare by 13.8% during the third quarter. Voya Investment Management LLC now owns 15,735 shares of the company’s stock worth $126,000 after acquiring an additional 1,912 shares in the last quarter. Citigroup Inc. raised its holdings in Aveanna Healthcare by 147.8% during the third quarter. Citigroup Inc. now owns 4,550 shares of the company’s stock worth $36,000 after acquiring an additional 2,714 shares in the last quarter. Pentwater Capital Management LP raised its holdings in Aveanna Healthcare by 1.4% during the fourth quarter. Pentwater Capital Management LP now owns 207,900 shares of the company’s stock worth $1,538,000 after acquiring an additional 2,900 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in Aveanna Healthcare by 15.2% during the fourth quarter. The Manufacturers Life Insurance Company now owns 23,433 shares of the company’s stock worth $173,000 after acquiring an additional 3,099 shares in the last quarter. Finally, Royal Bank of Canada raised its holdings in Aveanna Healthcare by 13.4% during the third quarter. Royal Bank of Canada now owns 27,058 shares of the company’s stock worth $216,000 after acquiring an additional 3,197 shares in the last quarter. Institutional investors and hedge funds own 67.39% of the company’s stock.

Shares of Aveanna Healthcare stock opened at $3.32 on Friday. The firm has a market cap of $613.30 million and a price-to-earnings ratio of -5.35. The stock’s 50-day moving average is $4.62 and its 200-day moving average is $6.14. Aveanna Healthcare has a one year low of $2.95 and a one year high of $13.00. The company has a debt-to-equity ratio of 1.93, a current ratio of 0.81 and a quick ratio of 0.81.

Aveanna Healthcare (NASDAQ:AVAHGet Rating) last issued its quarterly earnings results on Monday, March 28th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.01). Aveanna Healthcare had a negative net margin of 6.97% and a positive return on equity of 11.03%. On average, equities analysts expect that Aveanna Healthcare will post 0.4 EPS for the current year.

A number of equities research analysts recently commented on AVAH shares. Royal Bank of Canada decreased their price objective on Aveanna Healthcare from $16.00 to $9.00 and set an “outperform” rating for the company in a research note on Thursday, March 31st. Truist Financial decreased their price objective on Aveanna Healthcare from $10.00 to $5.00 and set a “buy” rating for the company in a research note on Wednesday, March 30th. Deutsche Bank Aktiengesellschaft decreased their price objective on Aveanna Healthcare from $12.50 to $6.00 and set a “buy” rating for the company in a research note on Wednesday, March 30th. Zacks Investment Research upgraded Aveanna Healthcare from a “sell” rating to a “hold” rating in a report on Friday, March 25th. Finally, Credit Suisse Group reduced their target price on Aveanna Healthcare from $12.00 to $9.50 and set an “outperform” rating on the stock in a report on Wednesday, March 30th. Three research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $8.90.

About Aveanna Healthcare (Get Rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.

Featured Stories

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.